Minerva Neurosciences Inc.
NERV | NASDAQ
$3.69
+$0.03 (+0.82%)
At close: Sep 21, 2026, 4:00 PM ET
$3.50
-$0.19 (-5.15%)
Pre-market:
Sep 22, 2026, 9:23 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 41.18M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | 41.18M |
Operating Income | -15.1M | -21.85M | -23.12M | -25.23M | -45.37M | 1.85M |
Interest Income | 948.12K | 1.27M | 1.44M | 556.95K | 16.52K | n/a |
Pretax Income | -293.42M | 1.44M | -30.01M | -32.11M | -51.71M | 1.94M |
Net Income | -293.42M | 1.44M | -30.01M | -32.11M | -49.91M | 1.94M |
Selling & General & Admin | 9.34M | 9.95M | 10.41M | 10.58M | 13.33M | 17.29M |
Research & Development | 5.76M | 11.9M | 12.71M | 14.65M | 32.04M | 22.04M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 15.1M | 21.85M | 23.12M | 25.23M | 45.37M | 39.33M |
Interest Expense | n/a | 4.56M | 8.28M | 7.41M | 6.33M | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 15.1M | 21.85M | 23.12M | 25.23M | 45.37M | 39.33M |
Income Tax Expense | n/a | n/a | n/a | n/a | -1.8M | n/a |
Shares Outstanding (Basic) | 8.46M | 7.57M | 6.51M | 5.34M | 5.34M | 5.1M |
Shares Outstanding (Diluted) | 8.46M | 7.57M | 6.51M | 5.34M | 5.34M | 5.12M |
EPS (Basic) | -34.67 | 0.19 | -4.61 | -6.01 | -9.35 | 0.38 |
EPS (Diluted) | -34.67 | 0.19 | -4.61 | -6.01 | -9.35 | 0.38 |
EBITDA | -293.42M | 6.02M | -21.69M | -24.69M | -45.28M | 2.12M |
EBIT | -293.42M | 6M | -21.72M | -24.7M | -45.38M | 1.94M |
Depreciation & Amortization | 5.44K | 22.47K | 30.98K | 8.51K | 101.79K | 176.18K |
Add to Watchlist
Select watchlists to add or remove NERV